G 409 (Propafenone Hydrochloride Extended-Release 325 mg)

Pill with imprint G 409 is White, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 325 mg. It is supplied by Glenmark Pharmaceuticals Inc., USA.

Propafenone is used in the treatment of atrial fibrillation; atrial flutter; ventricular tachycardia; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 325 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 409

Propafenone Hydrochloride Extended-Release

Imprint: G 409
Strength: 325 mg
Color: White
Size: 23.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Group I antiarrhythmics
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Glenmark Pharmaceuticals Inc., USA
Manufacturer: Glenmark Pharmaceuticals Limited
National Drug Code (NDC): 68462-0409
Inactive Ingredients: lactose monohydrate, microcrystalline cellulose, magnesium stearate, titanium dioxide, sodium lauryl sulfate, shellac, ferrosoferric oxide, potassium hydroxide
Note: Inactive ingredients may vary.